(603739)"Qingdao Vland Biotech Inc."Report for Q3 2026
Filed with SSE · Stock code 603739 · · 10 pages · Chinese
Summary by 6ix AI
The report confirms the accuracy and completeness of the financial information presented, with the board of directors taking legal responsibility for its content. Key financial data includes revenue and net profit figures, which indicate a decline compared to the previous year. The report also outlines the company's total assets and shareholders' equity as of the end of the reporting period.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Qingdao Vland Biotech Inc. on 6ix
Earlier from Qingdao Vland Biotech
- (603739)"Qingdao Vland Biotech Inc."Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- Announcement on Obtaining a New Veterinary Drug Registration Certificate
- Announcement on Appointment of Securities Affairs Representative
- Announcement on Obtaining New Veterinary Drug Registration Certificate
Follow Qingdao Vland Biotech into a list and get an email when it puts out news.
Follow Qingdao Vland Biotech